Inhibition of ASAH2 leads to an increase of Cer, which is accompanied with activation of apoptosis and autophagy, and a decreased survival of colon cancer cells, whereas its inhibition exerts only minimal effects in non-tumor intestinal cells. The gene discussed is CBLN1; the disease is colonic neoplasm.